Currently holds a position at NU Skin Enterprises Inc
Position | Company | Period |
---|---|---|
Executive Vice President - Product Development, Chief Scientific Officer | NU Skin Enterprises Inc | Feb. 1, 2006 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-03-03 | 2023-03-02 |
NU Skin Enterprises Inc
(NUS)
|
S Sale |
25,000
-54.1%
40.771,019,250 USD |
25,000 -54.1% | 40.77 | 1,019,250 USD | |
2023-03-03 | 2023-03-01 |
NU Skin Enterprises Inc
(NUS)
|
S Sale |
68,485
-76.3%
40.442,769,533 USD |
68,485 -76.3% | 40.44 | 2,769,533 USD | |
2022-06-02 | 2022-06-01 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
7,025
-23.4%
46.97329,964 USD |
7,025 -23.4% | 46.97 | 329,964 USD | |
2022-06-02 | 2022-06-01 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
8,975
-23.0%
46.25415,094 USD |
8,975 -23.0% | 46.25 | 415,094 USD | |
2022-03-03 | 2022-03-02 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
923
-3.9%
46.5342,947 USD |
923 -3.9% | 46.53 | 42,947 USD | |
2022-03-03 | 2022-03-02 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
2,500
-9.5%
45.86114,650 USD |
2,500 -9.5% | 45.86 | 114,650 USD | |
2022-03-01 | 2022-03-01 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
297
-1.3%
46.0413,674 USD |
297 -1.3% | 46.04 | 13,674 USD | |
2022-03-01 | 2022-03-01 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
28,280
-54.9%
45.211,278,539 USD |
28,280 -54.9% | 45.21 | 1,278,539 USD | |
2021-09-13 | 2021-09-13 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
16,000
-47.1%
47.41758,560 USD |
16,000 -47.1% | 47.41 | 758,560 USD | |
2021-03-10 | 2021-03-09 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
626
-3.4%
51.5532,270 USD |
626 -3.4% | 51.55 | 32,270 USD | |
2021-02-18 | 2021-02-18 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
1,125
-5.6%
49.7755,991 USD |
1,125 -5.6% | 49.77 | 55,991 USD | |
2020-09-10 | 2020-09-10 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
1,561
-9.5%
51.4880,360 USD |
1,561 -9.5% | 51.48 | 80,360 USD | |
2020-09-10 | 2020-09-10 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
5,308
-24.5%
50.69269,063 USD |
5,308 -24.5% | 50.69 | 269,063 USD | |
2020-09-10 | 2020-09-09 |
NU Skin Enterprises Inc
(NUS)
|
PS Planned sale |
9,931
-33.3%
49.92495,756 USD |
9,931 -33.3% | 49.92 | 495,756 USD | |
2020-06-08 | 2020-06-05 |
NU Skin Enterprises Inc
(NUS)
|
S Sale |
34,970
-48.0%
40.011,399,150 USD |
34,970 -48.0% | 40.01 | 1,399,150 USD | |
2017-03-27 | 2012-03-14 |
NU Skin Enterprises Inc
(NUS)
|
PP Planned purchase |
218
+0.4%
59.1312,890 USD |
218 +0.4% | 59.13 | 12,890 USD |